Brief: Inovio Announces Pricing Of Approximately $36 Mln Underwritten Offering Of Common Stock And Pre-Funded Warrants
15/04/2024 23:41
April 15 (Reuters) - Inovio Pharmaceuticals Inc INO.O :
* INOVIO ANNOUNCES PRICING OF APPROXIMATELY $36 MILLION
UNDERWRITTEN OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS
* INOVIO PHARMACEUTICALS INC - PRICING OF AN UNDERWRITTEN
OFFERING OF 2.5 MILLION SHARES OF ITS COMMON STOCK AT AN
OFFERING PRICE OF $7.693 PER SHARE
Source text for Eikon: ID:nPnbjtgVza
Further company coverage: INO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million